Corcept Therapeutics
CORT
64 hedge funds and large institutions have $214M invested in Corcept Therapeutics in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 4 closing their positions.
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
99% more capital invested
Capital invested by funds: $108M → $214M (+$107M)
54% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 13
29% more call options, than puts
Call options by funds: $49K | Put options by funds: $38K
23% more funds holding
Funds holding: 52 → 64 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.36M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
+$2.7M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$1.01M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$813K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
+$707K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
Investor AB
Stockholm,
Sweden
|
-$1.32M |
| 2 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
-$179K |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$73.1K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$51.5K |
| 5 |
SIM
Spark Investment Management
New York
|
-$50K |
CORT Hedge Fund Activity: Q1 2015 in Review
64 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2015, worth a combined $214M — up 99% from $108M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new CORT positions and 4 closed out — a net gain of 12 holders — while 20 added to existing stakes and 13 trimmed.
The largest buyer was Federated Hermes, adding an estimated $3.36M. The largest seller was Investor AB, cutting an estimated $1.32M.
- 64 institutional investors held Corcept Therapeutics (CORT) as of Q1 2015, up from 52 in Q4 2014.
- Funds reported $214M of Corcept Therapeutics stock for Q1 2015, up 99% quarter-over-quarter.
- 16 funds opened new Corcept Therapeutics positions in Q1 2015 and 4 closed out, a net change of +12 holders.
- The largest Corcept Therapeutics buyer in Q1 2015 was Federated Hermes, an estimated $3.36M added.
- The largest Corcept Therapeutics seller in Q1 2015 was Investor AB, an estimated $1.32M sold.
Based on aggregated 13F filings for Q1 2015.